SecBot SecBot
PRESS-RELEASE ·Filed Jul 20, 2026

THRM

Gentherm Inc
BULLISH
Impact 6/10
Horizonmonths Processed3mo ago WireGlobeNewswire
Press release · FDA
Actionable Insight ▲ Bullish

Monitor Q3 2026 earnings for initial ThermAffyx revenue and hospital adoption metrics. The 510(k) clearance is a positive catalyst for Gentherm's medical segment, but the stock's primary driver remains automotive thermal management. Watch for updates on hospital trial results and any subsequent partnership announcements.

DirectionBullish
Confidencehigh
Horizonmonths

How the stock moved after the report

BULLISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$36.64
T+0 close · Jul 20, 2026 · via day close
Latest settled
−15.26%
T+60 · $31.05
Vs SPY
−19.23%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jul 21 $36.64entry
  2. T+1 · 4mo ago −1.61%α −1.49% · $36.05
  3. T+5 · 4mo ago +14.82%α +16.05% · $42.07
  4. T+20 · 3mo ago +15.01%α +12.45% · $42.14
  5. T+60 · 5w ago −15.26%α −19.23% · $31.05
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Gentherm received FDA 510(k) clearance for its ThermAffyx Patient Safety System, a Class II medical device combining active patient warming, securement, and pressure reduction for robotic-assisted surgeries. Revenue generation is expected to begin in Q3 2026, with product trials starting in August. This expands Gentherm's medical portfolio beyond automotive thermal management, but the near-term financial impact is modest relative to the company's ~$1.5B annual revenue base.

Key Financial Metrics

Revenue
$1.5B

Key Facts

  • FDA 510(k) clearance for ThermAffyx Patient Safety System, a Class II medical device
  • Device combines active patient warming, securement, and pressure reduction for robotic-assisted surgeries
  • Product trials begin August 2026; revenue expected to commence in Q3 2026
  • Addresses a gap where only 17-21% of patient body surface area is available for forced-air warming in robotic procedures
  • Gentherm's 2025 annual sales were approximately $1.5 billion, with $2.2 billion in automotive new business awards

Financial Impact

Revenue generation expected to begin Q3 2026; near-term contribution modest relative to ~$1.5B annual sales

revenueproduct portfolio diversification

Risk Factors

  • Commercial adoption may be slower than expected in the competitive hospital market
  • Revenue contribution likely immaterial in the near term relative to automotive segment
  • No disclosed pricing or volume commitments from healthcare facilities

Market Snapshot

Exchange
Nasdaq
Sector
Motor Vehicle Parts & Accessories
Analyst Consensus
71% bullish (14 analysts)

Investment Themes

Industrials & Manufacturing

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3330082

Track record

25 reports on THRM

Performance horizon

1 of 6 bullish or bearish reports moved the stock their way by T+20. Best: +20.29% at T+60 after the Apr 23, 2026 report. 4 of 8 went positive at some point.

Filters
  1. Oct 26, 202621d ago Insider Cluster Bullish 4/10 Entry $31.82 Now $28.53 −10.34% settles Nov 24
  2. Oct 22, 202625d ago 8-K Bearish 6/10 Entry $26.15 Now $28.53 −9.10% settles Nov 19
  3. Oct 9, 20265w ago 8-K/A Neutral 5/10 Entry $30.92 to $30.38 Now $28.53 −7.73% ▼ −1.75% +1.52% vs SPY
  4. Oct 6, 20265w ago 3 Neutral 2/10 Entry $30.38 to $31.11 Now $28.53 −6.09% ▲ +2.40% +3.74% vs SPY
  5. Oct 1, 20266w ago 8-K Neutral 6/10 Entry $31.30 to $30.95 Now $28.53 −8.85% ▼ −1.12% +0.69% vs SPY
  6. Oct 1, 20266w ago Press Release Neutral 5/10 Entry $31.30 to $30.95 Now $28.53 −8.85% ▼ −1.12% +0.69% vs SPY
  7. Sep 17, 20268w ago Press Release Neutral 5/10 Entry $36.35 to $29.04 Now $28.53 −21.51% ▼ −20.11% −20.31% vs SPY
  8. Sep 11, 20269w ago 8-K Bullish 6/10 Entry $38.85 to $29.68 Now $28.53 −26.56% ▼ −23.60% −25.47% vs SPY
  9. Sep 10, 20269w ago Press Release Bullish 7/10 Entry $38.33 to $29.93 Now $28.53 −25.57% ▼ −21.91% −24.04% vs SPY
  10. Aug 13, 202613w ago EFFECT Neutral 3/10 Entry $43.07 to $38.85 Now $28.53 −33.76% ▼ −9.80% −8.05% vs SPY
Showing 10 of 25

US Market Status

Market Closed · Opens in 6h 26m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 20, 2026